Assessing the contribution of inflammation in models of Alzheimer's disease

Biochemical Society Transactions

Volumn 39, Issue 4, 2011, Pages 886-890

  Johnston, Hannah ^a   Boutin, Herve ^a   Allan, Stuart M ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Alzheimer's disease; Dementia; Inflammation; Transgenic model

Indexed keywords

AMYLOID BETA PROTEIN; AMYLOID PRECURSOR PROTEIN; BETA SECRETASE; CHEMOKINE RECEPTOR CX3CR1; CX3C CHEMOKINE; CYTOKINE; FRACTALKINE; GAMMA INTERFERON; GELATINASE B; INTERLEUKIN 1; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6; NONSTEROID ANTIINFLAMMATORY AGENT; PRESENILIN; TAU PROTEIN; TUMOR NECROSIS FACTOR; TUMOR NECROSIS FACTOR ALPHA;

AGE; ALZHEIMER DISEASE; BRAIN TISSUE; CELL ACTIVATION; CELL COMMUNICATION; CELL DEATH; CELL INFILTRATION; CONFERENCE PAPER; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DEMENTIA; DISEASE ASSOCIATION; DISEASE SEVERITY; EXPERIMENTAL MODEL; FAMILIAL AMYLOIDOSIS; HUMAN; INFLAMMATION; MICROGLIA; NERVE DEGENERATION; NONHUMAN; PATHOGENESIS; PHAGOCYTOSIS; PHENOTYPE; PRIORITY JOURNAL;

ALZHEIMER DISEASE; ANIMALS; CYTOKINES; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; MICE; MICE, TRANSGENIC; MICROGLIA; MONOCYTES; RATS;

EID: 79960880118     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0390886     Document Type: Conference Paper

References (49)

1. Blennow, K., de Leon, M.J. and Zetterberg, H. (2006) Alzheimer's disease. Lancet 368, 387-403 (Pubitemid 44108123)
2. Aizenstein, H.J., Nebes, R.D., Saxton, J.A., Price, J.C., Mathis, C.A., Tsopelas, N.D., Ziolko, S.K., James, J.A., Snitz, B.E., Houck, P.R. et al. (2008) Frequent amyloid deposition without significant cognitive impairment among the elderly. Arch. Neurol. 65, 1509-1517
3. Holmes, C., Boche, D., Wilkinson, D., Yadegarfar, G., Hopkins, V., Bayer, A., Jones, R.W., Bullock, R., Love, S., Neal, J.W. et al. (2008) Long-term effects of Aβ42 immunisation in Alzheimer's disease: follow-up of a randomised, placebo-controlled phase I trial. Lancet 372, 216-223 (Pubitemid 351978111)
4. Frank-Cannon, T.C., Alto, L.T., McAlpine, F.E. and Tansey, M.G. (2009) Does neuroinflammation fan the flame in neurodegenerative diseases? Mol. Neurodegener. 4, 47
5. Szekely, C.A. and Zandi, P.P. (2010) Non-steroidal anti-inflammatory drugs and Alzheimer's disease: the epidemiological evidence. CNS Neurol. Disord. Drug Targets 9, 132-139
6. Hollingworth, P., Harold, D., Jones, L., Owen, M.J. and Williams, J. (2010) Alzheimer's disease genetics: current knowledge and future challenges. Int. J. Geriatr. Psychiatr., doi:10.1002/gps.2628
7. Wyss-Coray, T. (2006) Inflammation in Alzheimer disease: driving force, bystander or beneficial response? Nat. Med. 12, 1005-1015
8. Gotz, J. and Gotz, N.N. (2009) Animal models for Alzheimer's disease and frontotemporal dementia: a perspective. ASN NEURO 1, e00019
9. Zahs, K.R. and Ashe, K.H. (2010) 'Too much good news': are Alzheimer mouse models trying to tell us how to prevent, not cure, Alzheimer's disease? Trends Neurosci. 33, 381-389
10. Allan, S.M. and Rothwell, N.J. (2003) Inflammation in central nervous system injury. Philos. Trans. R. Soc. London Ser. B 358, 1669-1677
11. Leon, W.C., Canneva, F., Partridge, V., Allard, S., Ferretti, M.T., DeWilde, A., Vercauteren, F., Atifeh, R., Ducatenzeiler, A., Klein, W. et al. (2010) A novel transgenic rat model with a full Alzheimer's-like amyloid pathology displays pre-plaque intracellular amyloid-β-associated cognitive impairment. J. Alzheimer's Dis. 20, 113-126
12. Stozicka, Z., Zilka, N., Novak, P., Kovacech, B., Bugos, O. and Novak, M. (2010) Genetic background modifies neurodegeneration and neuroinflammation driven by misfolded human tau protein in rat model of tauopathy: implication for immunomodulatory approach to Alzheimer's disease. J. Neuroinflamm. 7, 64
13. Hayes, A., Thaker, U., Iwatsubo, T., Pickering-Brown, S. and Mann, D. (2002) Pathological relationships between microglial cell activity and tau and amyloid β protein in patients with Alzheimer's disease. Neurosci. Lett. 331, 171-174
14. Cagnin, A., Brooks, D.J., Kennedy, A.M., Gunn, R.N., Myers, R., Turkheimer, F.E., Jones, T. and Banati, R.B. (2001) In-vivo measurement of activated microglia in dementia. Lancet 358, 461-467
15. Heneka, M.T., O'Banion, M.K., Terwel, D. and Kummer, M.P. (2010) Neuroinflammatory processes in Alzheimer's disease. J. Neural Transm. 117, 919-947
16. Maeda, J., Ji, B., Irie, T., Tomiyama, T., Maruyama, M., Okauchi, T., Staufenbiel, M., Iwata, N., Ono, M., Saido, T.C. et al. (2007) Longitudinal, quantitative assessment of amyloid, neuroinflammation, and anti-amyloid treatment in a living mouse model of Alzheimer's disease enabled by positron emission tomography. J. Neurosci. 27, 10957-10968 (Pubitemid 47574168)
17. Hanisch, U.K. and Kettenmann, H. (2007) Microglia: active sensor and versatile effector cells in the normal and pathologic brain. Nat. Neurosci. 10, 1387-1394
18. Streit, W.J., Braak, H., Xue, Q.S. and Bechmann, I. (2009) Dystrophic (senescent) rather than activated microglial cells are associated with tau pathology and likely precede neurodegeneration in Alzheimer's disease. Acta Neuropathol. 118, 475-485
19. Boissonneault, V., Filali, M., Lessard, M., Relton, J., Wong, G. and Rivest, S. (2009) Powerful beneficial effects of macrophage colony-stimulating factor on β-amyloid deposition and cognitive impairment in Alzheimer's disease. Brain 132, 1078-1092
20. Chen, K., Iribarren, P., Hu, J., Chen, J., Gong, W., Cho, E.H., Lockett, S., Dunlop, N.M. and Wang, J.M. (2006) Activation of Toll-like receptor 2 on microglia promotes cell uptake of Alzheimer disease-associated amyloid β peptide. J. Biol. Chem. 281, 3651-3659 (Pubitemid 43845983)
21. Arnaud, L., Robakis, N.K. and Figueiredo-Pereira, M.E. (2006) It may take inflammation, phosphorylation and ubiquitination to 'tangle' in Alzheimer's disease. Neurodegener. Dis. 3, 313-319
22. Hickman, S.E., Allison, E.K. and El, K.J. (2008) Microglial dysfunction and defective β-amyloid clearance pathways in aging Alzheimer's disease mice. J. Neurosci. 28, 8354-8360
23. Holmes, C., Cunningham, C., Zotova, E., Woolford, J., Dean, C., Kerr, S., Culliford, D. and Perry, V.H. (2009) Systemic inflammation and disease progression in Alzheimer disease. Neurology 73, 768-774
24. Perry, V.H., Cunningham, C. and Holmes, C. (2007) Systemic infections and inflammation affect chronic neurodegeneration. Nat. Rev. Immunol. 7, 161-167
25. Charo, I.F. and Ransohoff, R.M. (2006) The many roles of chemokines and chemokine receptors in inflammation. N. Engl. J. Med. 354, 610-621
26. Bhaskar, K., Konerth, M., Kokiko-Cochran, O.N., Cardona, A., Ransohoff, R.M. and Lamb, B.T. (2010) Regulation of tau pathology by the microglial fractalkine receptor. Neuron 68, 19-31
27. Lee, S., Varvel, N.H., Konerth, M.E., Xu, G., Cardona, A.E., Ransohoff, R.M. and Lamb, B.T. (2010) CX3CR1 deficiency alters microglial activation and reduces β-amyloid deposition in two Alzheimer's disease mouse models. Am. J. Pathol. 177, 2549-2562
28. Kitazawa, M., Oddo, S., Yamasaki, T.R., Green, K.N. and LaFerla, F.M. (2005) Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease. J. Neurosci. 25, 8843-8853 (Pubitemid 41384452)
29. Lee, D.C., Rizer, J., Selenica, M.L., Reid, P., Kraft, C., Johnson, A., Blair, L., Gordon, M.N., Dickey, C.A. and Morgan, D. (2010) LPS-induced inflammation exacerbates phospho-tau pathology in rTg4510 mice. J. Neuroinflamm. 7, 56
30. Herber, D.L., Roth, L.M., Wilson, D., Wilson, N., Mason, J.E., Morgan, D. and Gordon, M.N. (2004) Time-dependent reduction in Aβ levels after intracranial LPS administration in APP transgenic mice. Exp. Neurol. 190, 245-253
31. Lee, J.W., Lee, Y.K., Yuk, D.Y., Choi, D.Y., Ban, S.B., Oh, K.W. and Hong, J.T. (2008) Neuro-inflammation induced by lipopolysaccharide causes cognitive impairment through enhancement of β-amyloid generation. J. Neuroinflamm. 5, 37
32. Morgan, D., Gordon, M.N., Tan, J., Wilcock, D. and Rojiani, A.M. (2005) Dynamic complexity of the microglial activation response in transgenic models of amyloid deposition: implications for Alzheimer therapeutics. J. Neuropathol. Exp. Neurol. 64, 743-753
33. Griffin, W.S. and Mrak, R.E. (2002) Interleukin-1 in the genesis and progression of and risk for development of neuronal degeneration in Alzheimer's disease. J. Leukocyte Biol. 72, 233-238
34. Craft, J.M., Watterson, D.M., Hirsch, E. and Van Eldik, L.J. (2005) Interleukin 1 receptor antagonist knockout mice show enhanced microglial activation and neuronal damage induced by intracerebroventricular infusion of human β-amyloid. J. Neuroinflamm. 2, 15
35. Shaftel, S.S., Kyrkanides, S., Olschowka, J.A., Miller, J.N., Johnson, R.E. and O'Banion, M.K. (2007) Sustained hippocampal IL-1β overexpression mediates chronic neuroinflammation and ameliorates Alzheimer plaque pathology. J. Clin. Invest. 117, 1595-1604
36. Yirmiya, R. and Goshen, I. (2011) Immune modulation of learning, memory, neural plasticity and neurogenesis. Brain Behav. Immun. 25, 181-213
37. Allan, S.M., Tyrrell, P.J. and Rothwell, N.J. (2005) Interleukin-1 and neuronal injury. Nat. Rev. Immunol. 5, 629-640
38. Shaftel, S.S., Griffin, W.S. and O'Banion, M.K. (2008) The role of interleukin-1 in neuroinflammation and Alzheimer disease: an evolving perspective. J. Neuroinflamm. 5, 7
39. Chakrabarty, P., Ceballos-Diaz, C., Beccard, A., Janus, C., Dickson, D., Golde, T.E. and Das, P. (2010) IFN-γ promotes complement expression and attenuates amyloid plaque deposition in amyloid β precursor protein transgenic mice. J. Immunol. 184, 5333-5343
40. Yamamoto, M., Kiyota, T., Horiba, M., Buescher, J.L., Walsh, S.M., Gendelman, H.E. and Ikezu, T. (2007) Interferon-gamma and tumor necrosis factor-α regulate amyloid-β plaque deposition and β-secretase expression in Swedish mutant APP transgenic mice. Am. J. Pathol. 170, 680-692
41. Janelsins, M.C., Mastrangelo, M.A., Park, K.M., Sudol, K.L., Narrow, W.C., Oddo, S., Laferla, F.M., Callahan, L.M., Federoff, H.J. and Bowers, W.J. (2008) Chronic neuron-specific tumor necrosis factor-α expression enhances the local inflammatory environment ultimately leading to neuronal death in 3xTg-AD mice. Am. J. Pathol. 173, 1768-1782
42. He, P., Zhong, Z., Lindholm, K., Berning, L., Lee, W., Lemere, C., Staufenbiel, M., Li, R. and Shen, Y. (2007) Deletion of tumor necrosis factor death receptor inhibits amyloid β generation and prevents learning and memory deficits in Alzheimer's mice. J. Cell Biol. 178, 829-841
43. Shi, J.Q., Shen, W., Chen, J., Wang, B.R., Zhong, L.L., Zhu, Y.W., Zhu, H.Q., Zhang, Q.Q., Zhang, Y.D. and Xu, J. (2011) Anti-TNF-α reduces amyloid plaques and tau phosphorylation and induces CD11c-positive dendritic-like cell in the APP/PS1 transgenic mouse brains. Brain Res. 1368, 239-247
44. Chakrabarty, P., Jansen-West, K., Beccard, A., Ceballos-Diaz, C., Levites, Y., Verbeeck, C., Zubair, A.C., Dickson, D., Golde, T.E. and Das, P. (2010) Massive gliosis induced by interleukin-6 suppresses Aβ deposition in vivo: evidence against inflammation as a driving force for amyloid deposition. FASEB J. 24, 548-559
45. Heyser, C.J., Masliah, E., Samimi, A., Campbell, I.L. and Gold, L.H. (1997) Progressive decline in avoidance learning paralleled by inflammatory neurodegeneration in transgenic mice expressing interleukin 6 in the brain. Proc. Natl. Acad. Sci. U.S.A. 94, 1500-1505
46. Butovsky, O., Kunis, G., Koronyo-Hamaoui, M. and Schwartz, M. (2007) Selective ablation of bone marrow-derived dendritic cells increases amyloid plaques in a mouse Alzheimer's disease model. Eur. J. Neurosci. 26, 413-416
47. Simard, A.R., Soulet, D., Gowing, G., Julien, J.P. and Rivest, S. (2006) Bone marrow-derived microglia play a critical role in restricting senile plaque formation in Alzheimer's disease. Neuron 49, 489-502 (Pubitemid 43221886)
48. Simard, A.R. and Rivest, S. (2006) Neuroprotective properties of the innate immune system and bone marrow stem cells in Alzheimer's disease. Mol. Psychiatry 11, 327-335
49. Sastre, M., Richardson, J.C., Gentleman, S.M. and Brooks, D.J. (2011) Inflammatory risk factors and pathologies associated with Alzheimer's disease. Curr. Alzheimer Res. 8, 132-141